Stockscreener 앱 받기
7.65
6.10%
0.44
시간 외 거래:
8.33
0.68
+8.89%
전일 마감가:
$7.21
열려 있는:
$7.2
하루 거래량:
16,338
Relative Volume:
1.11
시가총액:
$9.65M
수익:
-
순이익/손실:
$-29.80M
주가수익비율:
-6.4286
EPS:
-1.19
순현금흐름:
$-25.19M
1주 성능:
-25.91%
1개월 성능:
-15.28%
6개월 성능:
-21.72%
1년 성능:
-40.07%
1일 변동 폭
$7.20
$7.65
1주일 범위
$7.20
$10.63
52주 변동 폭
$5.00
$17.40
센세이 바이오테라 Stock (SNSE) Company Profile
명칭
Sensei Biotherapeutics Inc
전화
(240) 243-8000
주소
1405 RESEARCH BLVD, SUITE 125, ROCKVILLE
SNSE을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SNSE
Sensei Biotherapeutics Inc
|
7.65 | 9.77M | 0 | -29.80M | -25.19M | -1.19 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
센세이 바이오테라 Stock (SNSE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-06-02 | 재개 | H.C. Wainwright | Buy |
| 2024-05-14 | 개시 | Stephens | Overweight |
| 2021-07-01 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-06-29 | 다운그레이드 | Oppenheimer | Outperform → Perform |
| 2021-03-01 | 개시 | Berenberg | Buy |
| 2021-03-01 | 개시 | Citigroup | Buy |
| 2021-03-01 | 개시 | Oppenheimer | Outperform |
| 2021-03-01 | 개시 | Piper Sandler | Overweight |
모두보기
센세이 바이오테라 주식(SNSE)의 최신 뉴스
Can you recover from losses in Sensei Biotherapeutics Inc.Steady Return Plan Based on Data Analysis - Newser
Ranking Sensei Biotherapeutics Inc. among high performing stocks via toolsMachine Learning Stock Price Forecast Tool - Newser
What momentum shifts mean for Sensei Biotherapeutics Inc.Free Beginner Friendly Stock Selection Guide - Newser
Published on: 2025-08-10 06:28:02 - Newser
Tick level data insight on Sensei Biotherapeutics Inc. volatilityFree Entry Alert Based on Volume Spikes - Newser
Sensei Biotherapeutics Inc. stock momentum explainedFree Breakout Entry Signal Confirmation Tool - Newser
Will a bounce in Sensei Biotherapeutics Inc. offer an exitLong-Term Stock Growth Forecast Insights - Newser
Published on: 2025-08-10 00:31:07 - Newser
How high can Sensei Biotherapeutics Inc. stock goBuy Signal System Based on Price Action - Newser
Key metrics from Sensei Biotherapeutics Inc.’s quarterly dataInsider Strategy for High Conviction Picks - Newser
Applying Wyckoff theory to Sensei Biotherapeutics Inc. stockVolume Based Swing Signal Prediction Map - Newser
How Sensei Biotherapeutics Inc. stock performs during market volatilityFree Breakout Confirmation With Entry Tracker - Newser
Sensei Biotherapeutics Inc.’s volatility index tracking explainedFree Access to Smart Investment Tips - Newser
What Fibonacci levels say about Sensei Biotherapeutics Inc. reboundMonthly Trade Result and Signal Summary - Newser
Published on: 2025-08-09 05:15:05 - Newser
Building trade automation scripts for Sensei Biotherapeutics Inc.Secure Entry Point Finder with Analysis - Newser
Chart based analysis of Sensei Biotherapeutics Inc. trendsSummary of Consistent Growth Stock Picks - Newser
What institutions are buying Sensei Biotherapeutics Inc. stock nowFree Trade Ready Stock Watch for Short Term - Newser
Is Sensei Biotherapeutics Inc. stock overhyped or has real potentialHigh Reward Investment Strategy for Beginners - Newser
Smart tools for monitoring Sensei Biotherapeutics Inc.’s price actionReal-Time AI Generated Market Forecast - Newser
Q3 EPS Estimate for Sensei Biotherapeutics Lifted by Analyst - Defense World
Short interest data insights for Sensei Biotherapeutics Inc.Smart Entry Signals for Active Traders - Newser
Sensei Biotherapeutics’ (SNSE) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Sensei Biotherapeutics (NASDAQ:SNSE) Given “Buy” Rating at HC Wainwright - Defense World
How to manage a losing position in Sensei Biotherapeutics Inc.Predictive Model for Intraday Swing Forecast - Newser
HC Wainwright Reiterates “Buy” Rating for Sensei Biotherapeutics (NASDAQ:SNSE) - Defense World
Sensei (SNSE) Q2 Loss Narrows 31% - AOL.com
Using RSI to spot recovery in Sensei Biotherapeutics Inc.Free Real Time Alerts Based on AI Prediction - Newser
Sensei Biotherapeutics Reports Promising Q2 2025 Results - TipRanks
Full technical analysis of Sensei Biotherapeutics Inc. stockMarket Timing Strategy with Technical Filters - Newser
Sensei Biotherapeutics, Inc. SEC 10-Q Report - TradingView
Sensei Biotherapeutics reports Q2 EPS ($3.91) vs ($5.69) last year - TipRanks
SNSE: HC Wainwright & Co. Raises Price Target to $30, Maintains Buy Rating | SNSE Stock News - GuruFocus
Sensei Biotherapeutics stock price target raised to $30 from $5 at H.C. Wainwright - Investing.com Canada
Sensei Biotherapeutics (SNSE) Price Target Raised to $30 by H.C. Wainwright - GuruFocus
Sensei Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Sensei Biotherapeutics Q2 basic EPS USD -3.91 - MarketScreener
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update | SNSE Stock News - GuruFocus
Sensei Biotherapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
Sensei's Cancer Drug Breakthrough: New Data Shows Effectiveness Where Other Treatments Failed - Stock Titan
센세이 바이오테라 (SNSE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.24%
3.39%
자본화:
|
볼륨(24시간):